Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  iobenguane I 131
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
Iobenguane I-131 in Treating Patients with Recurrent Neuroblastoma, Malignant Pheochromocytoma or Malignant Paraganglioma
Status: Active
Phase: Phase II
Type: Treatment
Age: Over 1
Trial IDs: 04-148, NCI-2016-00955, MSKCC-04148, NCT00107289
131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinistat
Status: Active
Phase: Phase II
Type: Treatment
Age: Over 24 months to less than 30 years
Trial IDs: N2011-01, NCI-2015-00640, NCT02035137
Vorinostat and Iobenguane I 131 in Treating Patients With Resistant or Relapsed Neuroblastoma
Status: Not yet active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 2 to 30
Trial IDs: NANT 2007-03, NCI-2009-01450, NANT-N2007-03, N2007-03, NCT01019850
Iobenguane I 131 in Treating Patients With Refractory Neuroblastoma
Status: Active
Phase: No phase specified
Type: Treatment
Age: 1 and over
Trial IDs: 05161, NCI-2011-01902, H854-26387, 10-01071, NCT01370330
Iobenguane I 131 in Treating Patients with Relapsed or Refractory Neuroblastoma or Metastatic Pheochromocytoma
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 1 and over
Trial IDs: 2012LS107, NCI-2013-01933, NCT01850888
Expanded Access Protocol Using I131-MIBG
Status: Active
Phase: No phase specified
Type: Treatment
Age: 12 months and over
Trial IDs: JDI2007-01, NCI-2014-01104, NCT01590680
Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma
Status: Not yet active
Phase: No phase specified
Type: Diagnostic
Age: Any age
Trial IDs: GE 122-008, NCI-2009-00926, NCT00730444
Start Over